Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anebulo Pharmaceuticals, Inc.

2.28
-0.0900-3.80%
Post-market: 2.280.00000.00%16:04 EST
Volume:20.44K
Turnover:48.00K
Market Cap:93.67M
PE:-9.09
High:2.39
Open:2.33
Low:2.28
Close:2.37
52wk High:3.42
52wk Low:0.8001
Shares:41.08M
Float Shares:3.40M
Volume Ratio:1.09
T/O Rate:0.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2509
EPS(LYR):-0.2509
ROE:-109.69%
ROA:-71.09%
PB:8.04
PE(LYR):-9.09

Loading ...

Anebulo Pharmaceuticals Explores Strategic Alternatives Update

TIPRANKS
·
Sep 12

Anebulo Pharmaceuticals provides update on going private transaction

TIPRANKS
·
Sep 12

BRIEF-Anebulo Pharmaceuticals Announces Update on Going Private Transaction and Strategic Alternatives

Reuters
·
Sep 12

Anebulo Pharmaceuticals Considers Reverse Stock Split Amid Strategic Alternatives Review

Reuters
·
Sep 12

Anebulo Pharmaceuticals Inc - Board May Abandon Reverse Stock Split Even IF Approved

THOMSON REUTERS
·
Sep 12

Anebulo Pharmaceuticals Inc - Receives Interest From Potential Partners

THOMSON REUTERS
·
Sep 12

Anebulo Pharmaceuticals Inc: Plan to Move Forward With Holding Special Stockholder Meeting to Approve Proposed Reverse Stock Split

THOMSON REUTERS
·
Sep 12

U.S. RESEARCH ROUNDUP- GE Vernova, NVR, ServiceNow

Reuters
·
Jul 24

Anebulo Pharmaceuticals Inc : Maxim Group Cuts to Hold From Buy

THOMSON REUTERS
·
Jul 24

Anebulo Pharmaceuticals Cut to Hold From Buy by Maxim Group

Dow Jones
·
Jul 24

Crude Oil Falls; Thermo Fisher Scientific Earnings Top Views

Benzinga
·
Jul 24

Anebulo Pharmaceuticals Inc : Benchmark Cuts to Hold Rating

THOMSON REUTERS
·
Jul 23

Anebulo Plans Reverse Stock Split to Terminate Registration of Its Stock; Shares Up

MT Newswires Live
·
Jul 23

BRIEF-Anebulo Pharmaceuticals Approves Plan To Terminate Registration Of Common Stock

Reuters
·
Jul 23

Anebulo Pharmaceuticals Inc - Stockholders to Receive $3.50 per Pre-Split Share

THOMSON REUTERS
·
Jul 23

Anebulo Pharmaceuticals Inc - Approves Reverse Stock Split Ratio Between 1-for-2,500 and 1-for-7,500

THOMSON REUTERS
·
Jul 23

Anebulo Pharmaceuticals Approves Plan to Terminate Registration of Its Common Stock

THOMSON REUTERS
·
Jul 23

Anebulo Pharmaceuticals Inc. Announces Date for Special Stockholder Meeting

Reuters
·
Jul 23